316 related articles for article (PubMed ID: 23369358)
1. Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.
Liu Y; Li Z; Zhang M; Deng Y; Yi Z; Shi T
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S17. PubMed ID: 23369358
[TBL] [Abstract][Full Text] [Related]
2. Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.
Lin PI; Shuldiner AR
Schizophr Res; 2010 Nov; 123(2-3):234-43. PubMed ID: 20832248
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide meta-analysis of genetic susceptible genes for Type 2 Diabetes.
Hale PJ; López-Yunez AM; Chen JY
BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S16. PubMed ID: 23281828
[TBL] [Abstract][Full Text] [Related]
4. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
Postolache TT; Del Bosque-Plata L; Jabbour S; Vergare M; Wu R; Gragnoli C
Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):186-203. PubMed ID: 30729689
[TBL] [Abstract][Full Text] [Related]
5. Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.
Hackinger S; Prins B; Mamakou V; Zengini E; Marouli E; Brčić L; Serafetinidis I; Lamnissou K; Kontaxakis V; Dedoussis G; Gonidakis F; Thanopoulou A; Tentolouris N; Tsezou A; Zeggini E
Transl Psychiatry; 2018 Nov; 8(1):252. PubMed ID: 30470734
[TBL] [Abstract][Full Text] [Related]
6. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
[TBL] [Abstract][Full Text] [Related]
7. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
[TBL] [Abstract][Full Text] [Related]
8. Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis.
Rahman MR; Islam T; Nicoletti F; Petralia MC; Ciurleo R; Fisicaro F; Pennisi M; Bramanti A; Demirtas TY; Gov E; Islam MR; Mussa BM; Moni MA; Fagone P
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562405
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci.
Luo X; Huang L; Jia P; Li M; Su B; Zhao Z; Gan L
Schizophr Bull; 2014 Jan; 40(1):39-49. PubMed ID: 23671194
[TBL] [Abstract][Full Text] [Related]
10. Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.
Irvin MR; Wiener HW; Perry RP; Savage RM; Go RC
Schizophr Res; 2009 Oct; 114(1-3):50-6. PubMed ID: 19643578
[TBL] [Abstract][Full Text] [Related]
11. Landscape of the relationship between type 2 diabetes and coronary heart disease through an integrated gene network analysis.
Dong C; Tang L; Liu Z; Bu S; Liu Q; Wang Q; Mai Y; Wang DW; Duan S
Gene; 2014 Apr; 539(1):30-6. PubMed ID: 24508273
[TBL] [Abstract][Full Text] [Related]
12. Untangling the genetic link between type 1 and type 2 diabetes using functional genomics.
Nyaga DM; Vickers MH; Jefferies C; Fadason T; O'Sullivan JM
Sci Rep; 2021 Jul; 11(1):13871. PubMed ID: 34230558
[TBL] [Abstract][Full Text] [Related]
13. Common Genetic Aberrations Associated with Metabolic Interferences in Human Type-2 Diabetes and Acute Myeloid Leukemia: A Bioinformatics Approach.
Kyriakou TC; Papageorgis P; Christodoulou MI
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502231
[TBL] [Abstract][Full Text] [Related]
14. Computational analyses of type 2 diabetes-associated loci identified by genome-wide association studies.
Cheng M; Liu X; Yang M; Han L; Xu A; Huang Q
J Diabetes; 2017 Apr; 9(4):362-377. PubMed ID: 27121852
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel type 2 diabetes candidate genes involved in the crosstalk between the mitochondrial and the insulin signaling systems.
Mercader JM; Puiggros M; Segrè AV; Planet E; Sorianello E; Sebastian D; Rodriguez-Cuenca S; Ribas V; Bonàs-Guarch S; Draghici S; Yang C; Mora S; Vidal-Puig A; Dupuis J; ; Florez JC; ; Zorzano A; Torrents D
PLoS Genet; 2012; 8(12):e1003046. PubMed ID: 23236286
[TBL] [Abstract][Full Text] [Related]
16. Shared molecular pathways and gene networks for cardiovascular disease and type 2 diabetes mellitus in women across diverse ethnicities.
Chan KH; Huang YT; Meng Q; Wu C; Reiner A; Sobel EM; Tinker L; Lusis AJ; Yang X; Liu S
Circ Cardiovasc Genet; 2014 Dec; 7(6):911-9. PubMed ID: 25371518
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
Mamakou V; Hackinger S; Zengini E; Tsompanaki E; Marouli E; Serafetinidis I; Prins B; Karabela A; Glezou E; Southam L; Rayner NW; Kuchenbaecker K; Lamnissou K; Kontaxakis V; Dedoussis G; Gonidakis F; Thanopoulou A; Tentolouris N; Zeggini E
BMC Psychiatry; 2018 Aug; 18(1):249. PubMed ID: 30071838
[TBL] [Abstract][Full Text] [Related]
18. Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data.
Fernández-Tajes J; Gaulton KJ; van de Bunt M; Torres J; Thurner M; Mahajan A; Gloyn AL; Lage K; McCarthy MI
Genome Med; 2019 Mar; 11(1):19. PubMed ID: 30914061
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the pituitary gland connects type 2 diabetes mellitus and schizophrenia based on large-scale trans-ethnic genetic analyses.
Cai L; Sun Y; Liu Y; Chen W; He L; Wei DQ
J Transl Med; 2022 Nov; 20(1):501. PubMed ID: 36329495
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.
Gragnoli C; Reeves GM; Reazer J; Postolache TT
Transl Psychiatry; 2016 Apr; 6(4):e785. PubMed ID: 27093067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
